Results 21 to 30 of about 2,252 (159)

The red hearing: swollen ear in a patient with ulcerative colitis [PDF]

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2014
Relapsing polychondritis is a rare connective tissue disease of unknown etiology characterized by recurrent inflammation, degeneration and deformity of auricular cartilage.
Paras Karmacharya   +3 more
doaj   +1 more source

Relapsing polychondritis associated with bilateral stapes footplate fixation: a case report

open access: yesJournal of Medical Case Reports, 2009
Introduction Relapsing polychondritis is a rare multisystem autoimmune disease of uncertain etiology characterized by recurrent episodes of inflammation and progressive destruction of cartilaginous tissues.
Takwoingi Yohanna M
doaj   +1 more source

A case of tracheobronchomalacia due to relapsing polychondritis treated with Montgomery T-tube

open access: yesSAGE Open Medical Case Reports, 2019
Relapsing polychondritis is a rare and multi-system autoimmune disease of unknown etiology characterized by inflammation and destruction of cartilaginous structures.
Nari Jeong   +6 more
doaj   +1 more source

Relapsing polychondritis with large airway involvement

open access: yesRespirology Case Reports, 2020
Relapsing polychondritis is a rare autoimmune condition characterized by episodic and progressive cartilaginous inflammation. Its clinical presentation is vastly divergent and can affect various organs.
Christiaan Yu, Simon A. Joosten
doaj   +1 more source

Relapsing polychondritis: prevalence of cardiovascular diseases and its risk factors, and general disease features according to gender

open access: yesRevista Brasileira de Reumatologia
The comorbidities in relapsing polychondritis have been scarcely described in the literature. Moreover, apart from a few relapsing polychondritis epidemiological studies, no studies specifically addressing relapsing polychondritis distribution according ...
Pablo Arturo Olivo Pallo   +3 more
doaj   +1 more source

Relapsing Polychondritis

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2009
Relapsing Polychondritis is an autoimmune disease that can present with a variety of non-specific symptoms involving the ears, nose, throat, head and neck.
Charina Melinda C. Elgar-Reyes   +1 more
doaj   +3 more sources

Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK centre

open access: yesERJ Open Research, 2021
Introduction Relapsing polychondritis is a rare multisystem vasculitis characterised by recurrent cartilage inflammation. Respiratory involvement, of which tracheobronchomalacia (TBM) is the commonest form, is difficult to treat and is linked to ...
Shirish Dubey   +9 more
doaj   +1 more source

Relapsing Polychondritis [PDF]

open access: yesSeminars in Respiratory and Critical Care Medicine, 2002
Relapsing polychondritis (RP) is a rare disease causing inflammation and destruction of cartilage and other connective tissues. Specific laboratory aberrations are lacking. Predominant clinical manifestations include auricular chondritis, polyarthritis, nasal chondritis, ocular inflammation, audiovestibular damage, and respiratory tract chondritis.
Bruce A, Staats   +2 more
openaire   +4 more sources

Relapsing Polychondritis Following Alopecia Areata

open access: yesCase Reports in Medicine, 2010
A case of alopecia areata followed by relapsing polychondritis is presented. Similar cases from the literature are reviewed and speculation about the relationship of these diseases is offered. Although the occurrence of these diseases together could be
John C. Starr   +2 more
doaj   +1 more source

Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune‐mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital‐based claims database

open access: yesJournal of Diabetes Investigation, EarlyView.
In this target trial emulation of patients with immune‐mediated inflammatory diseases and type 2 diabetes, SGLT2 inhibitor initiation was not associated with a clear increase in UTI risk versus metformin, including across immunosuppressive therapy strata.
Hiroshi Tsushima   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy